QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
NASDAQ:AMGN

Amgen - AMGN News Today

$249.70
-0.88 (-0.35%)
(As of 08/18/2022 05:45 PM ET)
Add
Compare
Today's Range
$247.95
$251.04
50-Day Range
$230.71
$253.15
52-Week Range
$198.64
$258.45
Volume
1.89 million shs
Average Volume
3.09 million shs
Market Capitalization
$133.57 billion
P/E Ratio
21.16
Dividend Yield
3.10%
Price Target
$245.14
Get Amgen News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMGN and its competitors with MarketBeat's FREE daily newsletter.

AMGN Media Mentions By Week

AMGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AMGN
News Sentiment

0.32

0.63

Average
Medical
News Sentiment

AMGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AMGN Articles
This Week

30

13

AMGN Articles
Average Week



SourceHeadline
marketbeat.com logoAmgen (NASDAQ:AMGN) Issues FY 2022 Earnings Guidance
marketbeat.com - August 18 at 7:02 AM
marketbeat.com logoTheStreet Upgrades Amgen (NASDAQ:AMGN) to "B"
marketbeat.com - August 17 at 7:25 AM
marketbeat.com logoTwo Appealing Biotech Stocks for Two Distinct investors (AMGN)
marketbeat.com - August 8 at 11:11 AM
marketbeat.com logoShould You Buy AbbVie Ahead Of Earnings? (AMGN)
marketbeat.com - July 28 at 8:40 AM
nasdaq.com logoAmgen (AMGN) is a Top-Ranked Value Stock: Should You Buy?
nasdaq.com - August 18 at 1:57 PM
nasdaq.com logoAMGEN Inc. Shares Close in on 52-Week High - Market Mover - Nasdaq
nasdaq.com - August 17 at 6:16 AM
nasdaq.com logoAmgen (AMGN) is a Top-Ranked Value Stock: Should You Buy? - Nasdaq
nasdaq.com - August 17 at 1:16 AM
stocknews.com logo5 Biotech Stocks in the Buy Zone This Week
stocknews.com - August 16 at 3:09 PM
finance.yahoo.com logoAmgen Moves to Dismiss Regeneron's Antitrust Case Regarding Cholesterol Drug
finance.yahoo.com - August 16 at 11:32 AM
stocknews.com logoDogs of the Dow: 2 Stocks to Buy and 2 to Hold
stocknews.com - August 15 at 5:43 PM
MarketBeat logoAmgen Inc. (AMGN) to Issue Quarterly Dividend of $1.94 on September 8th
americanbankingnews.com - August 15 at 7:20 AM
bizjournals.com logoAmgen deepens its roots in Tampa Bay - Tampa Bay Business Journal - The Business Journals
bizjournals.com - August 15 at 6:34 AM
finance.yahoo.com logoOnly Three Days Left To Cash In On Amgen's (NASDAQ:AMGN) Dividend
finance.yahoo.com - August 13 at 11:50 AM
nasdaq.com logoThe Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals - Nasdaq
nasdaq.com - August 12 at 9:01 AM
MarketBeat logoAmgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Oppenheimer
americanbankingnews.com - August 12 at 5:14 AM
seekingalpha.com logoAmgen under fire from Sen. Wyden over tax practices - Reuters (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 11 at 6:00 PM
reuters.com logoSenate Finance Committee looks at Amgen taxes, widening drugmaker probe - Reuters
reuters.com - August 11 at 6:00 PM
MarketBeat logoAmgen (NASDAQ:AMGN) Rating Lowered to Buy at StockNews.com
americanbankingnews.com - August 10 at 2:36 AM
seekingalpha.com logoAmgen data for new cancer agent shows liver toxicity with immunotherapies
seekingalpha.com - August 9 at 10:24 AM
MarketBeat logoEquities Analysts Offer Predictions for Amgen Inc.'s FY2023 Earnings (NASDAQ:AMGN)
americanbankingnews.com - August 9 at 3:56 AM
seekingalpha.com logoMRTX stock gains as Amgen posts new combination data for rival cancer drug (NASDAQ:MRTX) - Seeking Alpha
seekingalpha.com - August 8 at 2:52 PM
finance.yahoo.com logoAmgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
finance.yahoo.com - August 8 at 2:52 PM
finance.yahoo.com logoAMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022
finance.yahoo.com - August 8 at 2:52 PM
MarketBeat logoAmgen (NASDAQ:AMGN) Given New $236.00 Price Target at Royal Bank of Canada
americanbankingnews.com - August 8 at 4:36 AM
seekingalpha.com logoAmgen data for new cancer agent shows liver toxicity with immunotherapies (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 7 at 10:50 PM
seekingalpha.com logoAmgen Stock: Adding To The Pipeline (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 7 at 9:15 AM
reuters.com logoAmgen says Lumakras plus immunotherapy for lung cancer needs further study - Reuters
reuters.com - August 7 at 7:48 AM
markets.businessinsider.com logoAnalyst Ratings for Amgen
markets.businessinsider.com - August 7 at 4:15 AM
finance.yahoo.com logoAmgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
finance.yahoo.com - August 7 at 4:15 AM
benzinga.com logoAnalyst Ratings for Amgen - Benzinga
benzinga.com - August 6 at 8:13 AM
investors.com logoSiga Stock, Skyline, Amgen, Clearfield Among Best Stocks To Buy And Watch - Investor's Business Daily
investors.com - August 5 at 9:13 PM
benzinga.com logoWhat Are Whales Doing With Amgen - Benzinga
benzinga.com - August 5 at 2:58 AM
bloomberg.com logoAmgen Earnings Beat Estimates, Propelled by Top Drugs - Bloomberg
bloomberg.com - August 4 at 4:57 PM
finance.yahoo.com logoWhy ChemoCentryx Stock Is On Fire Today
finance.yahoo.com - August 4 at 10:29 AM
nasdaq.com logoAmgen Q2 22 Earnings Conference Call At 5:00 PM ET - Nasdaq
nasdaq.com - August 4 at 8:25 AM
finance.yahoo.com logoAMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
finance.yahoo.com - August 4 at 8:25 AM
finance.yahoo.com logoAMGEN ANNOUNCES 2022 THIRD QUARTER DIVIDEND
finance.yahoo.com - August 3 at 7:27 PM
finance.yahoo.com logoAMGEN APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS
finance.yahoo.com - August 3 at 7:27 PM
businesswire.com logo$964 Billion Worldwide Biotechnology Industry to 2027 - Featuring Amgen, Biogen, Novartis and Pfizer Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - August 3 at 9:26 AM
finance.yahoo.com logoAMGEN TO WEBCAST INVESTOR MEETING AT WCLC 2022
finance.yahoo.com - August 2 at 6:24 PM
finance.yahoo.com logoAmgen disputes tax allegations, BP raises dividend after strong quarter, CA declares monkeypox emergency - Yahoo Finance
finance.yahoo.com - August 2 at 1:24 PM
MarketBeat logoAmgen (AMGN) to Release Earnings on Thursday
americanbankingnews.com - August 2 at 1:46 AM
finance.yahoo.com logoAMGEN ANNOUNCES WEBCAST OF 2022 SECOND QUARTER FINANCIAL RESULTS - Yahoo Finance
finance.yahoo.com - August 2 at 12:12 AM
seekingalpha.com logoAmgen disputes IRS over $10.7B tax bill - WSJ
seekingalpha.com - August 1 at 7:11 PM
finance.yahoo.com logoAmgen (AMGN) to Report Q2 Earnings: What's in the Cards?
finance.yahoo.com - August 1 at 7:11 PM
finance.yahoo.com logoAMGEN ANNOUNCES WEBCAST OF 2022 SECOND QUARTER FINANCIAL RESULTS
finance.yahoo.com - August 1 at 7:10 PM
seekingalpha.com logoAmgen disputes IRS over $10.7B tax bill - WSJ (NASDAQ:AMGN) - Seeking Alpha
seekingalpha.com - August 1 at 2:10 PM
nasdaq.com logoAmgen (AMGN) to Report Q2 Earnings: What's in the Cards? - Nasdaq
nasdaq.com - August 1 at 2:10 PM
benzinga.com logoBenzinga Before The Bell: Alibaba's Delisting Concerns, Amgen's Potential $10.7B Tax Bill, Kenya Will Not - Benzinga
benzinga.com - August 1 at 10:42 AM
benzinga.com logoAmgen To Fight IRS Agency Over Tax Bill Of Whooping $10.7B: Report - Benzinga
benzinga.com - August 1 at 8:07 AM
wsj.com logoAmgen Fights IRS Over $10.7 Billion Tax Bill - The Wall Street Journal
wsj.com - August 1 at 8:07 AM
nasdaq.com logoAmgen Reaches Analyst Target Price
nasdaq.com - July 28 at 1:37 PM
benzinga.com logo$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - Benzinga - Benzinga
benzinga.com - July 27 at 7:19 PM
seekingalpha.com logoIDYA stock on watch as IDEAYA forms trial deal with Amgen for cancer agent (NASDAQ:IDYA) - Seeking Alpha
seekingalpha.com - July 27 at 2:18 PM
Get Amgen News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMGN and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:AMGN) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.